SCHEMBL13890889

SCHEMBL13890889

CC(=O)Nc1cc(Oc2ccccc2)ccc1C=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 1/20 0.49
MTNR1B P49286 1/20 0.49
GRIN1 Q05586 1/20 0.46
GRIN2B Q13224 1/20 0.46
EPHX1 P07099 1/20 0.46
GAA P10253 2/20 0.45
LMNA P02545 1/20 0.45
KMT2A Q03164 1/20 0.45
HPGD P15428 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
ACACB O00763 2/20 0.44
ACACA Q13085 2/20 0.44
HSP90AA1 P07900 1/20 0.44
HSP90AB1 P08238 1/20 0.44
ERN1 O75460 1/20 0.44
HDAC8 Q9BY41 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
ALDH1A1 P00352 2/20 0.42
TGM2 P21980 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15428172 0.85 PDK1 (0.44) GAALMNAKMT2AHPGDSMN1; SMN2
SCHEMBL9158501 0.83 MTNR1A (0.55) MTNR1AMTNR1BEPHX1GAAKMT2A
SCHEMBL4222097 0.82 CYP2C9 (0.57) MTNR1AMTNR1BEPHX1KMT2AHPGD
SCHEMBL9768767 0.82 TRIM24 (0.56) MTNR1AMTNR1BGAALMNAKMT2A
SCHEMBL4216870 0.81 HPGD (0.54) MTNR1AMTNR1BEPHX1GAALMNA
SCHEMBL14428222 0.80 PNLIP (0.61) GAALMNAKMT2AHPGDSMN1; SMN2
SCHEMBL11644513 0.79 HDAC2 (0.61) MTNR1AMTNR1BEPHX1GAALMNA
SCHEMBL14428460 0.79 L3MBTL1 (0.60) GAALMNAKMT2AHPGDNPC1
SCHEMBL14428191 0.79 RAB9A (0.47) LMNAKMT2ASMN1; SMN2HDAC8NPC1
SCHEMBL14428484 0.78 GAA (0.49) GAAHDAC8ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8327467-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2012-12-11 US disclosed
US-20090105474-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105474-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF MMP13, MMP11, MMP3 MTNR1A 946/4885MTNR1B 2530/4885GRIN1 1536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.